- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04098588
Behavioral Economics Intervention to Increase Treatment Seeking in the National Guard (BEAST)
November 3, 2022 updated by: University of Southern Mississippi
The study is a randomized controlled trial of a single-session behavioral economics (research combining the areas of economics, social psychology, and cognitive psychology) intervention (i.e., BEAST) is a"warrior-culture" consistent (i.e., focusing on positive soldier traits, solving practical problems), highly scalable, and extremely brief (10-minute) intervention to encourage treatment seeking among MS National Guard problems for various life stressors.
Participants will be 112 National Guard members.
It is hypothesized that BEAST will lead to more self-reported motivation to seek treatment and more actual treatment seeking behavior.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
112
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Mississippi
-
Hattiesburg, Mississippi, United States, 39406-0002
- University of Southern Mississippi
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- National Guard active
- > 17 ACSS-FAD
Exclusion Criteria:
- those determined by military or study personnel to be actively psychotic, manic, or who are imminently suicidal and in need of emergency services.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: BEAST
There are 3 parts to BEAST.
Part 1 involves the Behavioral Nudge technique using previously collected injunctive and descriptive norms from a National Guard sample.
Soldiers will be given a customized feedback form that shows norms relevant to the target behavior they selected.
The soldier will be given a chance to ask any follow-up questions.
Part 2 of the intervention focuses on the principle of targeting others, considering how a change would impact those closest to them.
Part 3 will utilize the Reciprocal Concessions procedure combined with the Reducing Barriers technique.
|
See Arm Description
|
|
Active Comparator: Descriptive Feedback
This condition will involve a presentation of descriptive data based on the soldiers' tests scores and an opportunity to ask any follow-up questions.
This process is a component of some behavioral change interventions (e.g., motivational interviewing); therefore this should be a more useful control condition (mirroring parts 1 and 2 of the active condition) versus a more passive or waitlist control condition.
Participants in the control condition will also be given standard referral information to the USM Psychology Clinic (mirroring part 3 of the active condition).
|
See Arm Description
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychosocial Treatments Interview-Revised
Time Frame: 1 month post intervention
|
Measure changes in treatment seeking behavior
|
1 month post intervention
|
|
University of Rhode Island Change Assessment
Time Frame: 1 month post intervention
|
Measure motivation to change the target behavior
|
1 month post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Psychosocial Treatments Interview-Revised
Time Frame: 3 month post intervention
|
Measure changes in treatment seeking behavior
|
3 month post intervention
|
|
University of Rhode Island Change Assessment
Time Frame: 3 month post intervention
|
Measure motivation to change the target behavior
|
3 month post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 15, 2019
Primary Completion (Anticipated)
March 29, 2023
Study Completion (Anticipated)
March 29, 2023
Study Registration Dates
First Submitted
September 18, 2019
First Submitted That Met QC Criteria
September 18, 2019
First Posted (Actual)
September 23, 2019
Study Record Updates
Last Update Posted (Actual)
November 4, 2022
Last Update Submitted That Met QC Criteria
November 3, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- W81XWH-16-2-0003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
After the study is completed will discuss with Department of Defense /Military Suicide Research Consortium on ability to share IPD.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Treatment Refusal
-
University of PadovaUniversity of Turin, ItalyNot yet recruiting
-
Boston Medical CenterMerck Sharp & Dohme LLCRecruitingVaccine Hesitancy | Vaccine RefusalUnited States
-
Johns Hopkins Bloomberg School of Public HealthMerck Sharp & Dohme LLC; Emory University; Children's Healthcare of AtlantaRecruitingVaccine Hesitancy | Vaccine RefusalUnited States
-
Emory UniversitySuspendedVaccination RefusalUnited States
-
University of YalovaActive, not recruitingChildren | Machine Learning | Vaccine Hesitancy | Vaccine RefusalTurkey (Türkiye)
-
Hospital Israelita Albert EinsteinMinistry of Health, BrazilRecruitingVaccine Hesitancy | Vaccine RefusalBrazil
-
Istanbul University - CerrahpasaActive, not recruitingChildhood ImmunizationTurkey (Türkiye)
-
Duke UniversityUniversity of South CarolinaCompletedVaccine HesitancyUnited States
-
The Children's Hospital of Zhejiang University...Not yet recruitingHPV | Vaccination Hesitancy | Biopsychosocial Model
-
Corewell Health EastMerck Sharp & Dohme LLCCompletedVaccine-Preventable Diseases | Physician-Patient Relations | Vaccine RefusalUnited States
Clinical Trials on BEAST
-
VA Office of Research and DevelopmentCompleted
-
Ohio UniversityCompletedAnxiety | Anxiety SensitivityUnited States
-
Norwegian School of Sport SciencesKarolinska Institutet; Linkoeping University; Norwegian Fund for Postgraduate... and other collaboratorsRecruiting